Loading...

AUPH AURINIA PHARMACEUTICALS INC Earnings Reports 8-K Filing

RN P

PH

AURINIA PHARMACEUTICALS INC

(AUPH)

2025 8-K

Merger Agreement Announced

Management Changes

Financial Results Report

Financial Results Update

Product Expansion

Financial Statements

Financial Results

Restructuring Announcement

Earnings Reports

Annual General Meeting of S...

Earnings Report

Departure of Executive Vice...

Financial Results, Program ...

Financial Results

Financial Results Announcement

Cooperation Agreement

New Directors Appointment

Earnings Report

Management Changes

AGM Voting Results

Earnings Reports

Positive Results from AUROR...

Confirmation of No Deposits...

Financial Results Announcement

Patent Allowance

Financial Results

Settlement Agreement

External Links:

On May 12, 2025, Aurinia Pharmaceuticals Inc. announced its financial results for the quarter ended March 31, 2025, reflecting its operational status. The filing is a routine quarterly earnings report and is considered significant.

AI Assistant

AURINIA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.